These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15517912)

  • 1. The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer.
    Sohda M; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Masuda N; Kuwano H
    Anticancer Res; 2004; 24(5A):3029-34. PubMed ID: 15517912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance and expression of insulin-like growth factor 1 and IGF binding protein 3 in serum of patients with lung cancer].
    Wang H; Wan YX; Zhang QK
    Ai Zheng; 2004 Jun; 23(6):710-4. PubMed ID: 15191678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY; Choi BG; Choi JY; Lee SY; Ju SY
    Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer.
    Yilmaz O; Eroglu A; Dag E; Karaoglanoglu N; Yilmaz A
    Int J Clin Pract; 2006 Dec; 60(12):1604-8. PubMed ID: 16704680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM
    Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
    Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
    Miyata Y; Sakai H; Hayashi T; Kanetake H
    Prostate; 2003 Feb; 54(2):125-32. PubMed ID: 12497585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma.
    Aishima S; Basaki Y; Oda Y; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Hosoi F; Maruyama Y; Fotovati A; Oie S; Ono M; Ueno T; Sata M; Yano H; Kojiro M; Kuwano M; Tsuneyoshi M
    Cancer Sci; 2006 Nov; 97(11):1182-90. PubMed ID: 16965600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC; Wu W; Tortolero-Luna G; Broaddus R; Gershenson DM; Burke TW; Schmandt R; Lu KH
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum level of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in acute coronary syndromes and relationship with prognosis].
    Sekuri C; Arslan O; Utük O; Bayturan O; Onur E; Tezcan UK; Tavli T
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):209-12. PubMed ID: 15355821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
    Kehinde EO; Akanji AO; Mojiminiyi OA; Bashir AA; Daar AS; Varghese R
    Prostate Cancer Prostatic Dis; 2005; 8(1):84-90. PubMed ID: 15775992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3.
    Pham TM; Fujino Y; Kikuchi S; Tamakoshi A; Yatsuya H; Matsuda S; Yoshimura T;
    Eur J Cancer; 2007 Jul; 43(10):1611-6. PubMed ID: 17532620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.